BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 113172
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.113172
Table 3 Univariate analysis of biomarker intensities: Comparison of Crohn's disease vs ulcerative colitis, mean ± SD

CD (n = 103)
UC (n = 46)
P value
Female, n (%)32 (31.1)21 (45.7)0.125
Ethnicity, n (%)0.02
    Western European77 (74.8)25 (54.3)
    South Asian9 (8.74)11 (23.9)
    Other17 (16.5)10 (21.7)
Age (year)12.5 ± 2.7113.6 ± 3.070.031
Biomarker
    CCL297.0 ± 36.8111 ± 52.60.113
    CCL51643 ± 11391624 ± 6650.897
    CCL7259 ± 144245 ± 1110.501
    IL-833.2 ± 18614.4 ± 9.540.307
    TSLP268 ± 119290 ± 1300.325
    CCL345.7 ± 15.543.9 ± 9.960.399
    CXCL1318 ± 253385 ± 3530.248
    CXCL2193 ± 155203 ± 2610.814
    CXCL94468 ± 34333171 ± 27630.016
    IL-18190 ± 218128 ± 91.00.016
    IL-2259.5 ± 19940.2 ± 16.90.331
    TARC293 ± 180403 ± 8020.362


Write to the Help Desk